ALERT: Due to the inclement weather across much of the country, Medtronic deliveries are currently experiencing delays and there will be longer than normal hold times on the phone. Visit www.Diabetes.shop if you need to place an order, get a sensor or belt clip replacement, or check the status of your supply order. X

News Releases


Medtronic Launches World's First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in U.S.

-November 15, 2022

DUBLIN, Nov. 15, 2022 /PRNewswire/ – Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. launch of Medtronic Extended infusion set, the first and only infusion set labelled for up to 7-day wear. An infusion set is tubing that delivers insulin from an insulin pump to the body and typically requires a set change every two to three days.

Read more >

Medtronic leverages data science to launch first-of-its-kind personalized insights program for people living with diabetes

-October 18, 2022

DUBLIN, Oct. 18, 2022 /PRNewswire/ – Medtronic plc (NYSE:MDT), the global leader in medical technology, is introducing a new program called My Insights exclusively made for individuals using the MiniMed™ 770G system. Using an individual's data, My Insights relies on the power of data science to provide personalized tips, trends, and reminders that customers can use to help with their diabetes management goals. The My Insights personalized recommendations are shared via a monthly email with educational content that is most relevant based on what an individual may currently be experiencing.

Read more >

CMS expands diabetes Medicare coverage to include CGMs that integrate with Medtronic insulin pumps

-December 22, 2021

Medicare coverage for Medtronic customers will be available 60 days after official publication

DUBLIN, Dec. 22, 2021 /PRNewswire/ – Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) will expand Medicare coverage for all types of continuous glucose monitors (CGMs), including adjunctive and non-adjunctive CGMs. This includes CGMs that integrate with Medtronic insulin pumps. The proposed rule was finalized on December 21, 2021 and will be effective starting 60 days after official publication.

Read more >

Medtronic Announces Ongoing Initiatives to Address Health Equity for People of Color Living with Diabetes

-April 7, 2021

New Partnerships and Research Efforts Prioritized Over the Next Three Years to Address Health Disparities

April 7, 2021 - MINNEAPOLIS, /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its ongoing commitment to health equity for people of color living with diabetes. The company committed investments in partnerships with the American Diabetes Association® (ADA) and T1D Exchange, as well as additional research efforts, to better understand and address these disparities.

Read more >

Medtronic Commends CMS on Proposed Rule to Expand Medicare Coverage for All CGMs

-October 28, 2020

October 28, 2020 – On October 27th, the Centers for Medicare & Medicaid Services (CMS) announced proposed new changes that, if finalized, would expand Medicare coverage for Continuous Glucose Monitors (CGMs) that provide critical information on glucose levels to help people with diabetes better manage their disease. We are very encouraged by CMS’s proposed rule and commend the agency on taking action to help more people with diabetes.

Read more >

View all announcements >





Media Inquiries

For media inquiries pertaining to the Diabetes Group of Medtronic, please contact:

Janet Cho
Sr Director, Global Communications
818-576-5014
janet.cho@medtronic.com

Ashley Patterson
818-576-3025
ashley.a.patterson@medtronic.com

For all other media inquiries please select the appropriate Global Public and Media Relations contact


Media Kits